Godsey & Gibb Inc’s Labcorp LH Stock Holding History

Godsey & Gibb Inc’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13	Closed	-$3K	–	127
2022 Q2	$3K	Buy	+13	New	+$2.77K	﹤0.01%	89

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Godsey & Gibb Inc's LH Position: Q3 2022 in Review

Godsey & Gibb Inc sold out of Labcorp (LH) in Q3 2022, closing a stake of 13 shares — an estimated $3K sold.

Godsey & Gibb Inc first reported a position in LH in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

Godsey & Gibb Inc reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
Godsey & Gibb Inc sold 13 Labcorp shares in Q3 2022, an estimated $3K.
Godsey & Gibb Inc first reported a position in Labcorp in Q2 2022 and held it in 1 quarter.
Godsey & Gibb Inc's Labcorp position peaked at $3K in Q2 2022.
936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Godsey & Gibb Inc's 13F filing for Q3 2022, filed 24 Oct 2022.